Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)

Rohto Pharmaceutical Co.,Ltd. Revenue

Rohto Pharmaceutical Co.,Ltd. had revenue of 70.73B JPY in the quarter ending September 30, 2024, with 6.04% growth. This brings the company's revenue in the last twelve months to 282.05B, up 10.08% year-over-year. In the fiscal year ending March 31, 2024, Rohto Pharmaceutical Co.,Ltd. had annual revenue of 270.84B with 13.48% growth.

• Revenue (ttm): 282.05B
• Revenue Growth: +10.08%
• P/S Ratio: 2.22
• Revenue / Employee: 38.86M
• Employees: 7,259
• Market Cap: 626.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%
Mar 31, 2020	188.33B	4.75B	2.58%